- Home
- AXG vs NKTR Comparison
AXG vs NKTR Comparison
Compare AXG & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AXG | NKTR |
|---|---|---|
| Founded | 2021 | 1990 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 763.8M | 807.8M |
| IPO Year | 2023 | 1994 |
Fundamental Metrics
Financial Performance| Metric | AXG | NKTR |
|---|---|---|
| Price | $4.41 | $37.43 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $111.83 |
| AVG Volume (30 Days) | 658.9K | ★ 758.2K |
| Earning Date | 01-09-2026 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $7,656,000.00 | ★ $62,600,000.00 |
| Revenue This Year | $28.53 | N/A |
| Revenue Next Year | $54.60 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 216.49 | N/A |
| 52 Week Low | $1.16 | $6.48 |
| 52 Week High | $5.09 | $66.92 |
Technical Indicators
Market Signals| Indicator | AXG | NKTR |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 35.18 |
| Support Level | N/A | $34.34 |
| Resistance Level | N/A | $45.34 |
| Average True Range (ATR) | 0.00 | 2.19 |
| MACD | 0.00 | -0.23 |
| Stochastic Oscillator | 0.00 | 29.00 |
Price Performance
Historical ComparisonAbout AXG Solowin Holdings Class A Ordinary Share
Solowin Holdings Ltd is an investor-focused, versatile securities brokerage company in Hong Kong. It offers a wide spectrum of products and services through its secure one-stop electronic platform. It is engaged in providing securities-related services, investment advisory services, and asset management services to customers. The operations were organized into four reportable segments: Corporate Finance Services, Wealth Management Services, Asset Management Services and Virtual Assets. It derives maximum revenue from Wealth Management Services.
About NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.